These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 12926088

  • 1. Expression of HER-2/neu in testicular tumors.
    Mandoky L, Geczi L, Bodrogi I, Toth J, Bak M.
    Anticancer Res; 2003; 23(4):3447-51. PubMed ID: 12926088
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical relevance of HER-2/neu overexpression in patients with testicular nonseminomatous germ cell tumor.
    Ghavamnasiri MR, Saeedi Saedi H, Shahid Sales S, Ghafarzadegan K.
    Urol J; 2010; 7(1):26-9. PubMed ID: 20209452
    [Abstract] [Full Text] [Related]

  • 7. Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment.
    Mandoky L, Szende B, Géczi L, Bodrogi I, Kásler M, Bak M.
    Anticancer Res; 2008; 28(3A):1641-9. PubMed ID: 18630521
    [Abstract] [Full Text] [Related]

  • 8. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE, Pollice AA, Smith CA, Janocko LE, Sweeney L, Brown KA, Singh SG, Gu L, Yakulis R, Lucke JF.
    Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
    [Abstract] [Full Text] [Related]

  • 9. Identification and relationship of HER-2/neu overexpression to short-term mortality in primary malignant brain tumors.
    Forseen SE, Potti A, Koka V, Koch M, Fraiman G, Levitt R.
    Anticancer Res; 2002 Apr; 22(3):1599-602. PubMed ID: 12168843
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Her-2/neu expression in testicular cancer--a retrospective analysis in 57 cases.
    Pfister D, Richter S, Thüer D, Giedl J, Heidenreich A, Klotz T.
    Urology; 2010 Nov; 76(5):1266.e6-9. PubMed ID: 21056276
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential expression of SOX2 and SOX17 in testicular germ cell tumors.
    Nonaka D.
    Am J Clin Pathol; 2009 May; 131(5):731-6. PubMed ID: 19369635
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.
    Wu Y, Soslow RA, Marshall DS, Leitao M, Chen B.
    Gynecol Oncol; 2004 Dec; 95(3):570-5. PubMed ID: 15581965
    [Abstract] [Full Text] [Related]

  • 19. TCL1 is a diagnostic marker for intratubular germ cell neoplasia and classic seminoma.
    Cao D, Lane Z, Allan RW, Wang P, Guo CC, Peng Y, Li J.
    Histopathology; 2010 Jul; 57(1):152-7. PubMed ID: 20553335
    [No Abstract] [Full Text] [Related]

  • 20. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
    Zhang DH, Tai LK, Wong LL, Sethi SK, Koay ES.
    Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.